ECTRIMS day one: refining multiple sclerosis diagnosis using MRI

Written by Peter Brown

Earlier this year, the Magnetic Resonance Imaging in Multiple Sclerosis (MAGNIMS) network published research in The Lancet Neurology, regarding a revision of guidelines for clinicians utilizing MRI scans when diagnosing early stage patients for MS. During the first day of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) congress, Paolo Preziosa (Vita-Salute San Raffaele University, Milan, Italy) presented the outlines of these results and demonstrated the potential capacity to utilize MRI scans to accurately diagnose individuals with few clinical signs of MS. MRI has been routinely utilized as a diagnostic tool for MS since 2001. Within the...

To view this content, please register now for access

It's completely free